Skip to content

CASI PHARMACEUTICALS, INC.

CIK 0000895051

← back to feed
Revenue (TTM)
$35.86M
+26.7% YoY FY Dec 2022
Net Income (TTM)
−$31.7M
−11.9% YoY FY Dec 2022
EPS Diluted (TTM)
−$1.73
+38.6% YoY FY Dec 2022
Gross Margin
58.5%
FY Dec 2022
Operating Margin
-78.9%
FY Dec 2022
Net Margin
-88.4%
FY Dec 2022
Free Cash Flow (TTM)
−$25.61M
FY Dec 2022
Cash
$47.11M
FY Dec 2022
Total Debt
$3.18M
FY Dec 2022
Shares Outstanding
13.46M sh
FY Dec 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings